ACR Meeting Abstracts
Abstract Number: 2429 • ACR/ARHP Annual Meeting 2018
Laura Andreoli1, Maria Chiara Gerardi2, Chiara Bazzani3, Matteo Filippini3, Micaela Fredi2, Roberto Gorla3, Maria Grazia Lazzaroni2, Cecilia Nalli2, Marco Taglietti3, Andrea Lojacono4, Sonia Zatti4, Mario Motta5 and Angela Tincani2, 1Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 2Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 3Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 4Obstetrics and Gynaecology, Spedali Civili and University of Brescia, Brescia, Italy, 5Neonatology and NICU, Spedali Civili of Brescia, Brescia, Italy
Background/Purpose: Treatment with tumor necrosis factors inhibitors (TNFi) during pregnancy may be required to control maternal disease which can be a threat for maternal-fetal well-being.…